Concise Summary of the Pfizer Phase I... - Fight Prostate Ca...

Fight Prostate Cancer

2,956 members1,313 posts

Concise Summary of the Pfizer Phase III Data

cujoe profile image
5 Replies

Here is a link to an excellent, concise summary of Pfizer's Phase III data for their COVID-19 vaccine. At the end it also provides links to the complete FDA and Pfizer documents for those who want more detail:

yourlocalepidemiologist.com...

Be Safe/Stay Well - K9

Written by
cujoe profile image
cujoe
To view profiles and participate in discussions please or .
5 Replies
cujoe profile image
cujoe

And an update on eligibility for it:

yourlocalepidemiologist.com...

marnieg46 profile image
marnieg46

Thank you cujoe. An interesting update and informative links.

I might have missed this in the info but in some of the news about the data I seem to recall those with anaphylaxis should avoid having the Pfizer vaccine. Although it's not expected to be approved here until March... I guess if that's the case...those with severe allergies shouldn't have it... that means Miss B&W can't have it. Maybe one of the other vaccines will be OK for that group. By the time the Pfizer is approved here, I suppose there will be a lot more data about side effects.

Regardless... a wonderful day that it is now available in the US to those most at risk. A light in a very dark tunnel.

cujoe profile image
cujoe in reply tomarnieg46

Marnie,

Here is what the NYT has to say about people with allergies taking the Pfizer vaccine.

nytimes.com/2020/12/11/heal...

Seems the HK has recommended against, so like me with my CLL-compromised immune function, there is justifiable reason to be cautious. I recently met with my CLL onco specialist (actually her NP this time), but it was just prior to the FDA approval and Pfizer data release, so no clear advice was offered. I will reach out to my cancer center for guidance before I rush out to get any of the vaccines. The standard line for immunocompromised patients is that, like most other vaccines, it will likely be less-effective than it is in the general population.

Time will tell for sure.

Stay Well and Enjoy your winter holiday in summer.

Ciao, K9

marnieg46 profile image
marnieg46 in reply tocujoe

Thank you. I will.

NPfisherman profile image
NPfisherman

K9 Terror,

Thanks for posting...

One of my concerns I raised previously is interactions with treatments and cancers, and I have not seen data on PCa and the mRNA vaccines...I am hoping that at some point, we shall see some info. Who knows?? It may be like the Dukoral vaccine epidemiological study and show benefit... Besides, I will not be at the top of the list now anyway, so no use worrying...

Fish

Not what you're looking for?

You may also like...

How Big Pharma and the Cost of Phase III clinical trials results in needless delays and deaths !!!

Greetings FPC amigos, I guess this article has been simmering inside me for a bit and I just had to...
NPfisherman profile image

Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with mHSPC - July 17, 2024

Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men...
cujoe profile image

Update on Prostate Cancer Vaccines from Previous Posts done over the last few years... and a new one...

Hello FPC forum, So after messaging with Soumen79, I realized that this was overdue... Over the...
NPfisherman profile image

Phase 3 ended: ECLIPSE trial of 177Lu-PSMA-I&T

A phase 3 clinical trial called ECLIPSE has shown that 177Lu-PSMA-I&T significantly extends the...
Maxone73 profile image

A look at the next generation of Androgen Receptor therapies--AR Degraders/PROTACS

Greetings FPC members, Recently, Cujoe the K9 Wonder asked me if ARV-110 might deserve a post and I...
NPfisherman profile image